Among them, LMTK2 has been identified as a susceptibility gene in prostate cancer and several other studies also highlighted that changes in LMTK2 and LMTK3 expressions can also be used as prognostic markers in colorectal, gastric, prostate and breast cancers4,5,10–12. The gene discussed is LMTK2; the disease is prostate carcinoma.